Investigating the impact of donor brain death duration on outcomes after lung transplant.

IF 6.7 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Alice J Coates, Samuel J Tingle, Dharesh Raj Amarnath, Georgios Kourounis, Andrew J Fisher, John H Dark
{"title":"Investigating the impact of donor brain death duration on outcomes after lung transplant.","authors":"Alice J Coates, Samuel J Tingle, Dharesh Raj Amarnath, Georgios Kourounis, Andrew J Fisher, John H Dark","doi":"10.1016/j.healun.2026.09.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Donor brain death induces haemodynamic and inflammatory changes that may influence organ quality and post-transplant outcomes. The impact of donor brain death duration on outcomes after lung transplantation remains uncertain.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study using the United Network for Organ Sharing database, including adult first-time lung transplant recipients from 2010 to December 2024. Donor brain death duration was defined as the interval between confirmation of donor brain death and donor cross-clamp. Missing data were addressed using multiple imputation. Multivariable Cox and logistic regression models assessed associations between brain death duration and post-transplant outcomes. Continuous variables were modeled using restricted cubic splines to preserve non-linear relationships.</p><p><strong>Results: </strong>About 31,178 patients were included. Median brain death duration was 49.8 hours (interquartile range 36.7-67.7). Longer brain death duration was independently associated with improved early outcomes, with a significant non-linear association with 90-day patient survival (p=0.004). A duration of 96 hours vs 24 hours was associated with improved 90-day patient survival (hazard ratio 0.73; 95% confidence interval 0.60-0.88). Similar associations were observed for 90-day graft survival. Longer duration was also associated with lower odds of 72-hour primary graft dysfunction (p=0.002) and 72-hour extracorporeal membrane oxygenation requirement (p<0.001). These associations were not sustained at 1 or 5 years.</p><p><strong>Conclusion: </strong>A longer duration between donor brain death and retrieval was associated with improved early outcomes, including lower 90-day patient mortality, without adverse long-term outcomes. These findings suggest that prolonged brain death duration alone should not negatively influence donor lung utilization decisions.</p>","PeriodicalId":15900,"journal":{"name":"Journal of Heart and Lung Transplantation","volume":" ","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2026-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart and Lung Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.healun.2026.09.006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Donor brain death induces haemodynamic and inflammatory changes that may influence organ quality and post-transplant outcomes. The impact of donor brain death duration on outcomes after lung transplantation remains uncertain.

Methods: We conducted a retrospective cohort study using the United Network for Organ Sharing database, including adult first-time lung transplant recipients from 2010 to December 2024. Donor brain death duration was defined as the interval between confirmation of donor brain death and donor cross-clamp. Missing data were addressed using multiple imputation. Multivariable Cox and logistic regression models assessed associations between brain death duration and post-transplant outcomes. Continuous variables were modeled using restricted cubic splines to preserve non-linear relationships.

Results: About 31,178 patients were included. Median brain death duration was 49.8 hours (interquartile range 36.7-67.7). Longer brain death duration was independently associated with improved early outcomes, with a significant non-linear association with 90-day patient survival (p=0.004). A duration of 96 hours vs 24 hours was associated with improved 90-day patient survival (hazard ratio 0.73; 95% confidence interval 0.60-0.88). Similar associations were observed for 90-day graft survival. Longer duration was also associated with lower odds of 72-hour primary graft dysfunction (p=0.002) and 72-hour extracorporeal membrane oxygenation requirement (p<0.001). These associations were not sustained at 1 or 5 years.

Conclusion: A longer duration between donor brain death and retrieval was associated with improved early outcomes, including lower 90-day patient mortality, without adverse long-term outcomes. These findings suggest that prolonged brain death duration alone should not negatively influence donor lung utilization decisions.

研究供体脑死亡持续时间对肺移植后预后的影响。
背景:供体脑死亡引起血流动力学和炎症变化,可能影响器官质量和移植后的预后。供体脑死亡持续时间对肺移植后预后的影响仍不确定。方法:我们使用联合器官共享网络数据库进行了一项回顾性队列研究,包括2010年至2024年12月的成人首次肺移植受者。供体脑死亡时间定义为确认供体脑死亡至供体交叉夹持的时间间隔。缺失的数据使用多重输入处理。多变量Cox和logistic回归模型评估了脑死亡持续时间与移植后预后之间的关系。连续变量使用受限三次样条进行建模,以保持非线性关系。结果:共纳入31,178例患者。中位脑死亡持续时间为49.8小时(四分位数间距为36.7-67.7)。较长的脑死亡持续时间与早期预后的改善独立相关,与90天患者生存率存在显著的非线性关联(p=0.004)。96小时与24小时的持续时间与患者90天生存率的提高相关(风险比0.73;95%可信区间0.60-0.88)。在90天的移植物存活率中也观察到类似的关联。较长的持续时间还与较低的72小时原发性移植物功能障碍(p=0.002)和72小时体外膜氧合需求(p)相关。结论:供体脑死亡和恢复之间较长的持续时间与改善的早期结果相关,包括较低的90天患者死亡率,无不良的长期结果。这些发现表明,脑死亡持续时间的延长本身不应该对供体肺的使用决定产生负面影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
10.10
自引率
6.70%
发文量
1667
审稿时长
69 days
期刊介绍: The Journal of Heart and Lung Transplantation, the official publication of the International Society for Heart and Lung Transplantation, brings readers essential scholarly and timely information in the field of cardio-pulmonary transplantation, mechanical and biological support of the failing heart, advanced lung disease (including pulmonary vascular disease) and cell replacement therapy. Importantly, the journal also serves as a medium of communication of pre-clinical sciences in all these rapidly expanding areas.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书